Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Cancer- and cancer treatment-related conditions
Stage/Subtype:  gastrointestinal complications
Country:  U.S.A.
Trial Type:  Supportive care
Trial Status:  Active
Results 1-25 of 40 for your search:
Start Over
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
Phase: Phase III
Type: Supportive care
Status: Active
Age: 1 to 21
Sponsor: Other
Protocol IDs: 06-08-367, NCT00726934
Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG 0920, CDR0000651536, NCI-2011-00878, NCT00956007
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
Phase: Phase III
Type: Supportive care
Status: Active
Age: 6 months to 21 years
Sponsor: NCI, Other
Protocol IDs: ACCL0934, NCI-2011-02636, CDR0000695661, COG-ACCL0934, U10CA095861, NCT01371656
A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: AAA-III-01, 2011-005049-11, NCT01578239
Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 11-497, NCT01617161
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG 1203, CDR0000738944, NCI-2012-02001, NCT01672892
Accelerating Gastrointestinal Recovery
Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 12-004082, NCT01704651
Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients.
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 18 to 70
Sponsor: Pharmaceutical / Industry
Protocol IDs: 988, NCT01804829
Randomized Trial of Glutamine in Patients With Mucositis or Esophagitis
Phase: Phase III
Type: Supportive care
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: 2013-0308, NCI-2014-00917, NCT01952847
EndoMAXX EVT Compared to EndoMAXX
Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: ESO-P3-12-02, NCT02159898
S1316, Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and Bowel Obstruction
Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: S1316, U10CA037429, 1R01HS021491-01A1, NCI-2014-01497, NCT02270450
The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer
Phase: Phase II, Phase I
Type: Supportive care
Status: Active
Age: Not specified
Sponsor: Pharmaceutical / Industry
Protocol IDs: SAL 2012-0584, NCT01739634
Probiotic LGG for Prevention of Side Effects in Patients Undergoing Chemoradiation for Gastrointestinal Cancer
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 201404101, NCT01790035
Compassionate Use of Omegaven® in the Treatment of Parenteral Nutrition Induced Hepatic Injury
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: MRMC 10-06, NCT01325584
Evaluate Esophageal Reinforcement With ACell MatriStem Surgical Matrix: A Degradable Biologic Scaffold Material
Phase: Phase II
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 13-178, NCT01970306
Efficacy Study of Alanyl-glutamine Supplementation for the Treatment of C. Difficile Infection
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: UVaHS-144404, NCT02053350
Pasireotide in Prevention of GI Toxicity
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: Pro00051736, NCT02215070
A Study Looking the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide
Phase: Phase II
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PUMA-NER-6201, NCT02400476
Rocking Motion: Physiologic Effect on the Surgical Stress Response
Phase: Phase I
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 2010-0129, NCI-2012-01884, 10445215, NCT01200316
Belinostat for Solid Tumors and Lymphomas in Patients With Varying Degrees of Hepatic Dysfunction
Phase: Phase I
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 110060, 11-C-0060, NCT01273155
A Study of The Impact of Severe Hepatic Impairment on the Pharmacokinetics and Safety of Vemurafenib in BRAF V600 Mutation-Positive Cancer Patients
Phase: Phase I
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: GO28053, 2012-003820-18, NCT01767623
Phone or Email Reminder in Increasing Vaginal Dilator Use in Patients With Gynecologic Cancers Undergoing Brachytherapy
Phase: Phase I
Type: Supportive care
Status: Active
Age: 19 and over
Sponsor: NCI, Other
Protocol IDs: GYN0005, NCI-2013-02400, 29074, P30CA124435, NCT02058550
Evaluation of Esomeprazole in Treating Gastro-Esophageal Reflux Disease (GERD) in Head and Neck Cancer Patients Exposed to Radiation Therapy
Phase: No phase specified
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 200308067, NCT00222079
Observational Study of Swallowing Function After Treatment of Advanced Laryngeal Cancer
Phase: No phase specified
Type: Natural history/Epidemiology, Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2008NTLS104, 0809M45481, NCT01089803
Reduced Planning Target Volume (PTV) Margins for the Treatment of Prostate Cancer Using the Calypso 4D Localization System
Phase: No phase specified
Type: Supportive care, Treatment
Status: Active
Age: 40 and over
Sponsor: Other
Protocol IDs: W81XWH-08-2-0174, A-15214.1a, 207111, NCT01589939
Start Over